{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:05:12Z","timestamp":1790888712518,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T00:00:00Z","timestamp":1734825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100022835","name":"Sociedad Espa\u00f1ola de Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.pcd.2024.12.002","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T04:25:50Z","timestamp":1735619150000},"page":"7-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care"],"prefix":"10.1016","volume":"19","author":[{"given":"D","family":"Orozco-Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mata-Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Artola-Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"\u00c1lvarez-Guisasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Cebri\u00e1n-Cuenca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcd.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1515\/CCLM.2003.182","article-title":"Haemoglobin A1c\u2014a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS)","volume":"41","author":"Manley","year":"2003","journal-title":"Clin. Chem. Lab Med"},{"key":"10.1016\/j.pcd.2024.12.002_bib2","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.pcd.2024.12.002_bib3","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic Targets: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib5","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib6","first-page":"1","article-title":"AACE medical guidelines for clinical practice for the management of diabetes mellitus","volume":"13","author":"American Association of Clinical Endocrinologist (AACE) Diabetes Mellitus Clinical Practice Guidelines Task Force","year":"2007","journal-title":"Endocr. Pr."},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib7","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)","volume":"28","author":"Ryden","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcd.2024.12.002_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc17-1414","article-title":"Long-term trends in antidiabetes drug usage in the U.S.: real-world evidence in patients newly diagnosed with type 2 diabetes","volume":"41","author":"Montvida","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2024.12.002_bib9","first-page":"S36","article-title":"State of diabetes care in the United States","volume":"13","author":"Blonde","year":"2007","journal-title":"Am. J. Manag Care"},{"issue":"6","key":"10.1016\/j.pcd.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s13300-024-01583-w","article-title":"Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis","volume":"15","author":"Newson","year":"2024","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2024.12.002_bib11","article-title":"The Association between body mass index and glycemic control in patients with type 2 diabetes across eight countries: a literature review","volume":"15","author":"Kennedy-Martin","year":"2021","journal-title":"Curr. Res Diabetes Obes. J."},{"issue":"4","key":"10.1016\/j.pcd.2024.12.002_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13300-024-01543-4","article-title":"Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study","volume":"15","author":"Hara","year":"2024","journal-title":"Diabetes Ther."},{"issue":"9","key":"10.1016\/j.pcd.2024.12.002_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107975","article-title":"Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data","volume":"35","author":"Boye","year":"2021","journal-title":"J. Diabetes Complicat."},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diabres.2010.10.002","article-title":"Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain","volume":"91","author":"Conthe","year":"2011","journal-title":"Diabetes Res Clin. Pr."},{"key":"10.1016\/j.pcd.2024.12.002_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1742-1241.2007.01367.x","article-title":"Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes in primary care. The gap between guidelines and reality in Spain","volume":"61","author":"Orozco-Beltr\u00e1n","year":"2007","journal-title":"Int J. Clin. Pr."},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0014-2565(04)71388-0","article-title":"Perfil de los pacientes con Diabetes Mellitus tipo 2, en la Atencio\u00b4n Primaria espa\u00f1ola","volume":"204","author":"Benito-L\u00f3pez","year":"2004","journal-title":"Rev. Clin. Esp."},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1186\/s12913-020-05360-w","article-title":"Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs","volume":"20","author":"Mata-Cases","year":"2020","journal-title":"BMC Health Serv. Res"},{"key":"10.1016\/j.pcd.2024.12.002_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.810757","article-title":"Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018","volume":"12","author":"Mata-Cases","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.pcd.2024.12.002_bib19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12902-016-0090-1","article-title":"Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain","volume":"16","author":"Mi\u00f1ambres","year":"2016","journal-title":"BMC Endocr. Disord."},{"issue":"3","key":"10.1016\/j.pcd.2024.12.002_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2976","article-title":"Spanish Society of Family Medicine Diabetes Group. Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real-life clinical practice","volume":"34","author":"Alvarez-Guisasola","year":"2018","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.pcd.2024.12.002_bib21","first-page":"290","article-title":"Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study","volume":"15","author":"Levy","year":"1998","journal-title":"Diabet. Care"},{"key":"10.1016\/j.pcd.2024.12.002_bib22","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycaemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus. Progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pcd.2024.12.002_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.medcli.2020.10.025","article-title":"Prevalence of obesity and abdominal obesity in Spanish population aged 65 years and over: ENPE study","volume":"158","author":"P\u00e9rez-Rodrigo","year":"2022","journal-title":"Med Clin. (Barc. )"},{"issue":"3","key":"10.1016\/j.pcd.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.recesp.2020.12.013","article-title":"Prevalence of obesity and associated cardiovascular risk factors in the Spanish population: the ENPE study","volume":"75","author":"P\u00e9rez-Rodrigo","year":"2022","journal-title":"Rev. Esp. Cardiol. (Engl. Ed. )."},{"key":"10.1016\/j.pcd.2024.12.002_bib25","unstructured":"Atlas mundial de obesidad 2023. \u3008https:\/\/s3-eu-west-1.amazonaws.com\/wof-files\/World_Obesity_Atlas_2023_Report.pdf\u3009. Last accessed 17\/10\/2023."},{"issue":"7","key":"10.1016\/j.pcd.2024.12.002_bib26","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/diacare.27.7.1535","article-title":"The burden of treatment failure in type 2 diabetes","volume":"27","author":"Brown","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pcd.2024.12.002_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc17-1414","article-title":"Long-term trends in antidiabetes drug usage in the U.S.: real-world evidence in patients newly diagnosed with type 2 diabetes","volume":"41","author":"Montvida","year":"2018","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib28","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/dc23-S006","article-title":"6. Glycemic Targets: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib29","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.2337\/dc23-S008","article-title":"on behalf of the American Diabetes Association. 8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pcd.2024.12.002_bib30","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1368-5031.2006.00799.x","article-title":"Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes","volume":"60","author":"Mateo","year":"2006","journal-title":"Int J. Clin. Pr."},{"key":"10.1016\/j.pcd.2024.12.002_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/fampra\/cmp053","article-title":"Clinica inertia in general practice: widespread and related to the outcomes of diabetes care","author":"Van Bruggen","year":"2009","journal-title":"Fam. Pr."},{"key":"10.1016\/j.pcd.2024.12.002_bib32","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s11606-007-0433-8","article-title":"Reasons for not intensifying medications: differentiating \u2018\u2018clinical inertia\u2019\u2019 from appropriate care","volume":"22","author":"Safford","year":"2007","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.pcd.2024.12.002_bib33","first-page":"S36","article-title":"State of diabetes care in the United States","volume":"13","author":"Blonde","year":"2007","journal-title":"Am. J. Manag Care"},{"issue":"8","key":"10.1016\/j.pcd.2024.12.002_bib34","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1185\/030079906X112750","article-title":"Time to pharmacotherapy change in response to elevated HbA1c test results","volume":"22","author":"Yood","year":"2006","journal-title":"Curr. Med Res Opin."},{"key":"10.1016\/j.pcd.2024.12.002_bib35","unstructured":"Gu\u00eda de diabetes tipo 2 para cl\u00ednicos. Fundaci\u00f3n redGDPS, 2018. ISBN: 978-84-944007-6-6."},{"issue":"10","key":"10.1016\/j.pcd.2024.12.002_bib36","first-page":"611","article-title":"en representaci\u00f3n del Grupo de Trabajo de Consensos y Gu\u00edas Cl\u00ednicas. Spanish Diabetes Society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 Update","volume":"65","author":"Gomez-Peralta","year":"2018","journal-title":"Endocrinol. Diabetes Nutr. (Engl. Ed. )"},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib37","first-page":"95","article-title":"Comprehensive approach to people with type 2 diabetes. Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition","volume":"70","author":"Reyes-Garc\u00eda","year":"2023","journal-title":"Endocrinol. Diabetes Nutr. (Engl. Ed. )."},{"issue":"4","key":"10.1016\/j.pcd.2024.12.002_bib38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00125-019-05078-3","article-title":"Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)","volume":"63","author":"Aschner","year":"2020","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.pcd.2024.12.002_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2976","article-title":"Spanish Society of Family Medicine Diabetes Group. Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: Implications in real-life clinical practice","volume":"34","author":"Alvarez-Guisasola","year":"2018","journal-title":"Diabetes Metab. Res Rev."},{"key":"10.1016\/j.pcd.2024.12.002_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.810757","article-title":"Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018","volume":"12","author":"Mata-Cases","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.pcd.2024.12.002_bib41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s13300-024-01543-4","article-title":"Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study","volume":"15","author":"Hara","year":"2024","journal-title":"Diabetes Ther."},{"key":"10.1016\/j.pcd.2024.12.002_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jdiacomp.2015.11.016","article-title":"Obesity and glycemic control in patients with diabetes mellitus: analysis of physician electronic health records in the US from 2009\u20132011","volume":"30","author":"Bae","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.pcd.2024.12.002_bib43","article-title":"Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data","volume":"385","author":"Bidulka","year":"2024","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.pcd.2024.12.002_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107975","article-title":"Obesity and glycemic control among people with type 2 diabetes in the United States: A retrospective cohort study using insurance claims data","volume":"35","author":"Boye","year":"2021","journal-title":"J. Diabetes Complicat."},{"issue":"6","key":"10.1016\/j.pcd.2024.12.002_bib45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.diabet.2019.01.006","article-title":"Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settings","volume":"45","author":"Guerci","year":"2019","journal-title":"Diabetes Metab."},{"issue":"1","key":"10.1016\/j.pcd.2024.12.002_bib46","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.jcjd.2017.10.034","article-title":"Pharmacologic Glycemic Management of Type 2 Diabetes in Adults","volume":"42","author":"Lipscombe","year":"2018","journal-title":"Can. J. Diabetes"},{"issue":"8","key":"10.1016\/j.pcd.2024.12.002_bib47","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1377\/hlthaff.2010.0023","article-title":"Renewing primary care: lessons learned from the Spanish health care system","volume":"29","author":"Borkan","year":"2010","journal-title":"Health Aff. (Millwood)"},{"issue":"2","key":"10.1016\/j.pcd.2024.12.002_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pcd.2008.03.001","article-title":"Primary care diabetes in Spain","volume":"2","author":"Orozco-Beltran","year":"2008","journal-title":"Prim. Care Diabetes"}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991824002377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991824002377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T04:11:28Z","timestamp":1740629488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991824002377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1751991824002377"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2024.12.002","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycemic and weight control in people with type 2 diabetes: A real-world observational study in primary care","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}